MedPath

江苏黄河药业股份有限公司

Ownership
-
Established
1999-12-21
Employees
-
Market Cap
-
Website
www.hham.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

148

NMPA:148

Drug Approvals

肾康宁胶囊

Approval Number
国药准字Z20090877
Approval Date
Mar 25, 2024
NMPA

Gliclazide Modified Release Tablets

Product Name
格列齐特缓释片
Approval Number
国药准字H20093682
Approval Date
Dec 5, 2023
NMPA

丹黄祛瘀片

Approval Number
国药准字Z20090718
Approval Date
Sep 1, 2023
NMPA

乳癖康胶囊

Approval Number
国药准字Z20090378
Approval Date
Sep 1, 2023
NMPA

虎力散片

Approval Number
国药准字Z20090606
Approval Date
Sep 1, 2023
NMPA

复方一枝蒿片

Approval Number
国药准字Z20080595
Approval Date
May 23, 2023
NMPA

保心胶囊

Approval Number
国药准字Z20080158
Approval Date
Feb 8, 2023
NMPA

参芪肝康片

Approval Number
国药准字Z20080109
Approval Date
Feb 8, 2023
NMPA

Amlodipine Besilate Tablets

Product Name
苯磺酸氨氯地平片
Approval Number
国药准字H20083618
Approval Date
Dec 20, 2022
NMPA

Lisinopril Tablets

Product Name
赖诺普利片
Approval Number
国药准字H20066146
Approval Date
Mar 5, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.